The current management of gastrointestinal stromal tumors.

[1]  K. Lillemoe,et al.  Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior , 2003, Journal of Gastrointestinal Surgery.

[2]  T. Nicol,et al.  Complete hepatic resection of metastases from leiohyosarcoma prolongs survival , 1998, Journal of Gastrointestinal Surgery.

[3]  T. Kosaka,et al.  Prognostic factors in primary gastrointestinal leiomyosarcoma: A retrospective study , 1991, World Journal of Surgery.

[4]  Rossella Bertulli,et al.  Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial , 2004, The Lancet.

[5]  J. Blay,et al.  Outcome of patients with advanced gastro-intestinal stromal tumors (GIST) crossing over to a daily imatinib dose of 800mg (HD) after progression on 400mg (LD) - an international, intergroup study of the EORTC, ISG and AGITG. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Gerald Antoch,et al.  Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  M. van Glabbeke,et al.  Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group. , 2004, European journal of cancer.

[8]  M. Martínez-González,et al.  Gastrointestinal autonomic nerve tumours and their separation from other gastrointestinal stromal tumours: an ultrastructural and immunohistochemical study of seven cases , 2004, Virchows Archiv.

[9]  E. Lerma,et al.  Stromal tumours of the gastrointestinal tract: a clinicopathological and ploidy analysis of 33 cases , 2004, Virchows Archiv.

[10]  K. Hunt,et al.  Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? , 2003, American journal of surgery.

[11]  A. D. Van den Abbeele,et al.  Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  S. Mocellin,et al.  Gastrointestinal stromal tumors: From a surgical to a molecular approach , 2003, International journal of cancer.

[13]  E. Gaffney,et al.  Gastrointestinal stromal tumours , 2003, The British journal of surgery.

[14]  N. Moriyama,et al.  Gastrointestinal Stromal Tumor: Correlation of Computed Tomography Findings with Tumor Grade and Mortality , 2003, Journal of computer assisted tomography.

[15]  S. Hirota,et al.  Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. , 2003, Gastroenterology.

[16]  D. Brewster,et al.  Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach , 2003, Histopathology.

[17]  A. Lazaris,et al.  Prognostic predictors of gastrointestinal stromal tumors: a multi-institutional analysis of 102 patients with definition of a prognostic index. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[18]  B. Nilsson,et al.  Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients , 2003, British Journal of Cancer.

[19]  L. Pajor,et al.  Frequent occurrence of low grade cases among metastatic gastrointestinal stromal tumours , 2003, Journal of clinical pathology.

[20]  T. Okai,et al.  Endosonographic evaluation of c-kit-positive gastrointestinal stromal tumor , 2003, Abdominal Imaging.

[21]  C. Fisher,et al.  Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. , 2003, Radiology.

[22]  Samuel Singer,et al.  PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors , 2003, Science.

[23]  A. D. Van den Abbeele,et al.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. , 2002, The New England journal of medicine.

[24]  J. Goldblum,et al.  Gastric Stromal Tumors: A Clinicopathologic Study of 77 Cases With Correlation of Features With Nonaggressive and Aggressive Clinical Behaviors , 2002, The American journal of surgical pathology.

[25]  L. Sobin,et al.  Diagnosis of Gastrointestinal Stromal Tumors:A Consensus Approach , 2002, International journal of surgical pathology.

[26]  S. Mocellin,et al.  Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis , 2002, Cancer.

[27]  Sigrid Stroobants,et al.  Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study , 2001, The Lancet.

[28]  D. Tuveson,et al.  Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. , 2001, The New England journal of medicine.

[29]  B. Yeap,et al.  The effect of surgery and grade on outcome of gastrointestinal stromal tumors. , 2001, Archives of surgery.

[30]  M. V. van Velthuysen,et al.  The histopathological differential diagnosis of gastrointestinal stromal tumours , 2001, Journal of clinical pathology.

[31]  A. Davis,et al.  Malignant Gastrointestinal Stromal Tumors of the Small Intestine: A Review of 50 Cases From a Prospective Database , 2001, Annals of Surgical Oncology.

[32]  S. Hirota,et al.  Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. , 2000, The American journal of pathology.

[33]  R. Foster,et al.  Tumors of the Rectum and Anal Canal , 2000, World Journal of Surgery.

[34]  J. Skandalakis,et al.  Tumors of the Appendix and Colon , 2000, World Journal of Surgery.

[35]  J. Skandalakis,et al.  Tumors of the Small Intestine , 2000, World Journal of Surgery.

[36]  R. Foster,et al.  Tumors of the Stomach , 2000, World Journal of Surgery.

[37]  J. Skandalakis,et al.  Tumors of the Esophagus , 2000, World Journal of Surgery.

[38]  L. Sobin,et al.  Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. , 2000, The American journal of surgical pathology.

[39]  L. Palazzo,et al.  Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours , 2000, Gut.

[40]  R. DeMatteo,et al.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. , 2000, Annals of surgery.

[41]  G. Rosen,et al.  Surgical Resection and Intraperitoneal Chemotherapy for Recurrent Abdominal Sarcomas , 1999, Annals of Surgical Oncology.

[42]  S. Hirota,et al.  Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. , 1999, Cancer research.

[43]  Edvardsson,et al.  Expression of c‐kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumours , 1999, Histopathology.

[44]  O. Merimsky,et al.  Gastrointestinal stromal sarcomas , 1999, The British journal of surgery.

[45]  L. Sobin,et al.  KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[46]  J. Woodruff,et al.  Role of electron microscopy in the evaluation of soft tissue neoplasms, with emphasis on spindle cell and pleomorphic tumors. , 1998, Human pathology.

[47]  M. Fukayama,et al.  Telomerase activity in gastrointestinal stromal tumors , 1998 .

[48]  Y. Hirooka,et al.  Preliminary Results of Fine Needle Aspiration Biopsy Histology in Upper Gastrointestinal Submucosal Tumors , 1998, Endoscopy.

[49]  R. Parwaresch,et al.  Immunophenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: a multivariate clinicopathologic study. , 1998, Human pathology.

[50]  L. Kindblom,et al.  Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. , 1998, The American journal of pathology.

[51]  R. Nelson,et al.  Fine-needle aspiration of gastrointestinal stromal tumors. , 1998, American journal of clinical pathology.

[52]  J. Byun,et al.  Gastrointestinal leiomyoma and leiomyosarcoma: CT differentiation. , 1998, Journal of computer assisted tomography.

[53]  S. Carpenter,et al.  Endosonographic differentiation of benign and malignant stromal cell tumors. , 1997, Gastrointestinal endoscopy.

[54]  L. Traverso,et al.  Gut stromal tumors and their clinical behavior. , 1997, American journal of surgery.

[55]  M. Silverman,et al.  Gastric Smooth Muscle Tumors: Diagnostic Dilemmas and Factors Affecting Outcome , 1996, World Journal of Surgery.

[56]  Jürg Zimmermann,et al.  Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells , 1996, Nature Medicine.

[57]  C. Papadimitriou,et al.  Immunohistochemical phenotyping and PCNA detection in gastrointestinal stromal tumors. , 1995, Anticancer research.

[58]  D. Franquemont.  Differentiation and risk assessment of gastrointestinal stromal tumors. , 1995, American journal of clinical pathology.

[59]  E. Lerma,et al.  Ploidy of 36 stromal tumors of the gastrointestinal tract. A comparative study with flow cytometry and image analysis. , 1994, Analytical and quantitative cytology and histology.

[60]  H. Goldman,et al.  Stromal tumors of the stomach: prognostic value of the PCNA index. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[61]  J. Papadimitriou,et al.  Gastrointestinal Autonomic Nerve Tumors: A Clinicopathological, Immunohistochemical And Ultrastructural Study Of 10 Cases , 1994, Pathology.

[62]  E. Casper,et al.  Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. , 1993, The American journal of surgical pathology.

[63]  R. Pollock,et al.  Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas , 1992, Cancer.

[64]  P. Quirke,et al.  A Flow Cytometric, Clinical, and Histological Study of Stromal Neoplasms of the Gastrointestinal Tract , 1992, The American journal of surgical pathology.

[65]  C. Fletcher,et al.  A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AGNOR) staining, and histological grading in gastrointestinal stromal tumours , 1992, The Journal of pathology.

[66]  A. Zinsmeister,et al.  Gastric leiomyosarcoma. Prognostic factors and surgical management. , 1991, Archives of surgery.

[67]  S. Wallace,et al.  Regression of hepatic metastases from gastrointestinal leiomyosarcoma after hepatic arterial chemoembolization , 1991, Cancer.

[68]  G. Williams,et al.  Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease) , 1991, Histopathology.

[69]  W. Meyers,et al.  Abdominal Leiomyosarcoma: Aggressive Management , 1989, Southern medical journal.

[70]  N. Ordóñez,et al.  Ultrastructural observations on smooth muscle tumors. , 1987, Ultrastructural pathology.

[71]  Y. Lee,et al.  Leiomyosarcoma of the gastro-intestinal tract: general pattern of metastasis and recurrence. , 1983, Cancer treatment reviews.